Associate Director leading innovation initiatives for LGBTQ+ health at Penn. Overseeing project execution and sustainability strategies to improve health outcomes.
About the role
- Senior Director responsible for setting strategic direction for delivery system innovation at Lilly. Managing partnerships and overseeing early-stage development portfolios across diverse drug delivery solutions.
Responsibilities
- Define and drive the DDCS delivery system innovation strategy, establishing the vision, priorities, and sourcing mix (internal and external) for the early-phase pipeline in alignment with Lilly’s therapeutic and commercial objectives.
- Build and lead Lilly’s external delivery system innovation ecosystem—forging strategic relationships with academic institutions, venture-backed startups, technology accelerators, CDMOs, and device partners to access and in-license best-in-class delivery technologies ahead of the industry.
- Establish and own the governance framework, stage-gate criteria, and investment decision process for the DDCS early innovation portfolio, ensuring disciplined, data-driven advancement from ideation through proof-of-concept and into formalized development.
- Provide strategic counsel to DDCS senior leadership and the broader Device organization on external innovation trends, competitive landscape, emerging technologies, and portfolio gaps; translate insights into actionable investment theses.
- Champion a culture of innovation and external curiosity across DDCS, building organizational capability in technology scouting, opportunity assessment, and cross-sector collaboration.
- Accountable for the overall health, prioritization, and performance of the DDCS early-phase development portfolio—setting direction for program leads and ensuring alignment between portfolio investments and strategic priorities.
- Integrate portfolio intelligence across internal programs and external partnerships into a unified, leadership-ready view of pipeline status, resource requirements, risks, and investment opportunities for annual business planning and capital allocation.
- Drive DDCS-wide adoption of standardized early development processes, governance frameworks, and innovation metrics, institutionalizing best practices across internal and externally sourced programs.
- Serve as an interface with Lilly enterprise functions—Global Business Development, Corporate Strategy, Research, and Therapeutic Business Units—to ensure alignment between delivery system innovation and drug development priorities.
- Represent DDCS at external conferences, industry consortia, and partner forums; build Lilly’s reputation as a preferred innovation partner in the delivery system and drug-device combination space.
- Influence resource allocation, organizational design, and capability investment decisions within DDCS in support of early-phase innovation strategy.
Requirements
- Advanced degree (PhD, MD, or equivalent) in engineering, pharmaceutical sciences, or a related technical field
- 10+ years of progressive leadership in delivery system development, medical device innovation, or drug-device combination product development in a regulated environment, with demonstrated accountability at a senior director or equivalent level.
- Strategic thinking with the ability to synthesize complex technical, commercial, and competitive inputs into clear priorities and decisive recommendations.
- Exceptional communication and influence skills; able to engage effectively with C-suite and Board-level stakeholders, external partners, and cross-functional leadership.
- Proven track record of building and leading external innovation programs at enterprise scale, including deal sourcing, technology evaluation, partnership structuring, and integration of externally originated programs into internal development pipelines.
- Demonstrated ability to define and execute innovation strategies across a large organization, with experience translating strategic priorities into portfolio investment decisions, stage-gate governance, and resource allocation.
- Deep expertise in the external innovation ecosystem relevant to drug delivery: knowledge of startup and venture landscapes, academic technology transfer, CDMO innovation capabilities, and industry consortia in the delivery system space.
- Established external network in the delivery system, medical device, or drug-device combination space; recognized as an industry thought leader or active participant in relevant professional communities.
- Expert-level ability to evaluate and communicate the technical, regulatory, and commercial viability of novel delivery technologies to both technical and non-technical senior leadership audiences.
- Strong business acumen with experience constructing investment cases, structuring partnership agreements, and managing external spending at a portfolio level.
- Demonstrated record of intellectual property portfolio development, including patent strategy and prosecution, or technology in-licensing in delivery system innovation; published thought leadership or speaking engagements at major industry forums (e.g., Drug Delivery Partnerships, PDA, AAPS)
- Experience with international innovation sourcing, partnership models across regulatory jurisdictions, and global development programs
- Six Sigma Black Belt, PMP, or equivalent advanced project and quality management credentials.
Benefits
- eligibility to participate in a company-sponsored 401(k)
- pension
- vacation benefits
- eligibility for medical, dental, vision and prescription drug benefits
- flexible benefits (e.g., healthcare and/or dependent day care flexible spending accounts)
- life insurance and death benefits
- certain time off and leave of absence benefits
- well-being benefits (e.g., employee assistance program, fitness benefits, and employee clubs and activities)
Job title
Job type
Experience level
Salary
Degree requirement
Tech skills
Location requirements
Associate Director of Biostatistics leading clinical biostatistics globally in drug development. Collaborating with cross - functional teams and mentoring statisticians for innovative statistical methods.
Associate Director leading medical information strategy for Regeneron’s therapeutic areas. Managing tactical execution of medical affairs plans and providing scientific support for healthcare professionals.
Associate Director driving Lean Transformation and Continuous Improvement in a global healthcare leader. Engaging with business leaders to enhance operational performance across multiple sites.
Executive Director leading oncology asset development and drug strategy at a healthcare company. Responsible for strategies across all phases from discovery to reimbursement.
Associate Director for Contracts providing senior - level leadership in negotiating complex research agreements. Overseeing compliance and operational procedures in grants and contracts within Rice University.
Director overseeing eDiscovery delivery operations at Kroll in India. Leading a high - performing team for complex investigations and litigation support.
Regional Director of Outreach leading the outreach team in the Southeast US, focusing on behavioral health relationships and ensuring strategic goals are met. Responsibilities include team development, outreach strategy, and stakeholder engagement.
Director managing strategic advocacy initiatives to ensure patient access for Johnson & Johnson Innovative Medicine. Developing partnerships and executing plans to shape healthcare policies affecting access.
Regional Director managing Cardiovascular sales and clinical teams within D.C./Virginia. Aiming to improve patient outcomes while achieving sales growth in medical device sector.